| Dr Zeeshan Ashraf Danawala, MD | |
|
135 Vision Park Blvd, Shenandoah, TX 77384-3001 | |
| (281) 404-3000 | |
| Not Available |
| Full Name | Dr Zeeshan Ashraf Danawala |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 14 Years |
| Location | 135 Vision Park Blvd, Shenandoah, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609192558 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | Q5169 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baylor Scott & White Medical Center - Frisco | Frisco, TX | Hospital |
| Baylor Scott & White The Heart Hospital - Plano | Plano, TX | Hospital |
| Medical City Plano | Plano, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Dallas Urology Associates | 5395710933 | 12 |
News Archive
Researchers at Mount Sinai School of Medicine in New York have found new clues in the pathogenesis of skull and skin birth defects associated with a rare genetic disorder, Beare-Stevenson cutis gyrata syndrome.
Autopsy data of 221 men and women found that the brains of one-third of individuals who had dementia before death showed evidence of small, cumulative blood vessel damage that can arise from hypertension or diabetes.
Psychologists from Cardiff University have developed the first self-assessment test designed to help clinicians diagnose autism in adults.
The Malaria Policy Advisory Committee, convened by the WHO Global Malaria Programme and composed of 15 malaria experts, will hold its first meeting January 31 through February 2 in Geneva, according to this article in Malaria Journal, which is a prelude to a series on the group's policy recommendations and supporting evidence that will be published following each biannual meeting.
Cochlear Limited, the global leader in implantable hearing solutions, announced today that the U.S. Food and Drug Administration (FDA) has approved the Cochlear™ Nucleus® 6 Sound Processor for use with the Nucleus 22 Cochlear Implant, giving those who have worn cochlear implants from the beginning (over 20 years in some cases) access to the latest breakthroughs in true wireless and automatic hearing. Released in 1985, the Nucleus 22 Implant was the first commercially available multi-channel cochlear implant in the world.
› Verified 8 days ago
| Entity Name | North Dallas Urology Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669419107 PECOS PAC ID: 5395710933 Enrollment ID: O20040827000818 |
News Archive
Researchers at Mount Sinai School of Medicine in New York have found new clues in the pathogenesis of skull and skin birth defects associated with a rare genetic disorder, Beare-Stevenson cutis gyrata syndrome.
Autopsy data of 221 men and women found that the brains of one-third of individuals who had dementia before death showed evidence of small, cumulative blood vessel damage that can arise from hypertension or diabetes.
Psychologists from Cardiff University have developed the first self-assessment test designed to help clinicians diagnose autism in adults.
The Malaria Policy Advisory Committee, convened by the WHO Global Malaria Programme and composed of 15 malaria experts, will hold its first meeting January 31 through February 2 in Geneva, according to this article in Malaria Journal, which is a prelude to a series on the group's policy recommendations and supporting evidence that will be published following each biannual meeting.
Cochlear Limited, the global leader in implantable hearing solutions, announced today that the U.S. Food and Drug Administration (FDA) has approved the Cochlear™ Nucleus® 6 Sound Processor for use with the Nucleus 22 Cochlear Implant, giving those who have worn cochlear implants from the beginning (over 20 years in some cases) access to the latest breakthroughs in true wireless and automatic hearing. Released in 1985, the Nucleus 22 Implant was the first commercially available multi-channel cochlear implant in the world.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Zeeshan Ashraf Danawala, MD 135 Vision Park Blvd, Shenandoah, TX 77384-3001 Ph: (281) 404-3000 | Dr Zeeshan Ashraf Danawala, MD 135 Vision Park Blvd, Shenandoah, TX 77384-3001 Ph: (281) 404-3000 |
News Archive
Researchers at Mount Sinai School of Medicine in New York have found new clues in the pathogenesis of skull and skin birth defects associated with a rare genetic disorder, Beare-Stevenson cutis gyrata syndrome.
Autopsy data of 221 men and women found that the brains of one-third of individuals who had dementia before death showed evidence of small, cumulative blood vessel damage that can arise from hypertension or diabetes.
Psychologists from Cardiff University have developed the first self-assessment test designed to help clinicians diagnose autism in adults.
The Malaria Policy Advisory Committee, convened by the WHO Global Malaria Programme and composed of 15 malaria experts, will hold its first meeting January 31 through February 2 in Geneva, according to this article in Malaria Journal, which is a prelude to a series on the group's policy recommendations and supporting evidence that will be published following each biannual meeting.
Cochlear Limited, the global leader in implantable hearing solutions, announced today that the U.S. Food and Drug Administration (FDA) has approved the Cochlear™ Nucleus® 6 Sound Processor for use with the Nucleus 22 Cochlear Implant, giving those who have worn cochlear implants from the beginning (over 20 years in some cases) access to the latest breakthroughs in true wireless and automatic hearing. Released in 1985, the Nucleus 22 Implant was the first commercially available multi-channel cochlear implant in the world.
› Verified 8 days ago
Paul Rizk, MD Urology Medicare: Medicare Enrolled Practice Location: 135 Vision Park Blvd, Shenandoah, TX 77384 Phone: 281-404-3000 Fax: 936-273-6911 | |
John George Giannakis, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 135 Vision Park Blvd, Shenandoah, TX 77384 Phone: 281-404-3000 Fax: 936-273-6911 | |
Paul Richard Kenworthy, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 135 Vision Park Blvd, Shenandoah, TX 77384 Phone: 281-404-3000 Fax: 936-273-6911 | |
Ronald Glover Henry, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 135 Vision Park Blvd, Shenandoah, TX 77384 Phone: 281-404-3000 Fax: 936-273-6911 | |
Michael Francis Graham Jr., MD Urology Medicare: Accepting Medicare Assignments Practice Location: 135 Vision Park Blvd, Shenandoah, TX 77384 Phone: 281-404-3000 Fax: 936-273-6911 | |
Dr. Brenda Tharian, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 129 Vision Park Blvd Ste 301, Shenandoah, TX 77384 Phone: 936-647-2184 Fax: 936-647-2201 |